The health edit
NUTRITION & HEALTHY AGING
Can a different diet change your biological age?
A small trial found changes in aging-related biomarkers. What that tells us—and what it leaves unanswered.
RECENTLY PUBLISHED
-
Nutrient-Matched Ultraprocessed Meal Triggered a Larger Insulin Response
A randomized crossover study found different short-term insulin, energy-use and brain responses after nutrient-matched ultraprocessed and non-ultraprocessed meals.
-
Walnuts and visceral fat: what a 12-week randomized trial found
A 12-week randomized trial found faster changes in abdominal-fat measures with a walnut-based lower-carbohydrate diet, but no significant between-group differences at the endpoint.
-
INSIGNIA 50″ Class F50 Series LED 4K UHD Smart Fire TV, Voice Remote with Alexa, Stream Live TV Without Cable $159.99
Limited-time deal $159.99 with 47 percent savings-47% $159.99 List Price: $299.99 List Price: $299.99 Check It Out! Share on FacebookTweetFollow usSave
Recent research, explained
-
Nutrient-Matched Ultraprocessed Meal Triggered a Larger Insulin Response
A randomized crossover study found different short-term insulin, energy-use and brain responses after nutrient-matched ultraprocessed and non-ultraprocessed meals.
-
Walnuts and visceral fat: what a 12-week randomized trial found
A 12-week randomized trial found faster changes in abdominal-fat measures with a walnut-based lower-carbohydrate diet, but no significant between-group differences at the endpoint.
-
High-polyphenol olive oil: what the small HEVOOC trial actually shows
A small randomized crossover trial confirms greater phenolic exposure, while metabolic benefits remain exploratory.
BEHIND THE HEADLINE
A younger biomarker profile isn’t proof of a longer life.
Research reported May 12, 2026 · Small randomized trial · 4 weeks
In a trial of 104 adults aged 65–75, several diet changes improved a biological-age estimate based on 20 biomarkers. The clearest statistical signal came from the omnivorous, higher-carbohydrate group.
The important limit: the trial did not establish longer life or fewer diseases. It excluded people with conditions including type 2 diabetes and cancer, so the findings cannot simply be applied to everyone.
From Let’s Talk Health
Full articles from 2025 onward on food, movement, and healthy aging.
-
Can early type 2 diabetes enter remission? What the RESET trial found
A randomized trial found 54% remission after an intensive supervised diet-and-exercise program, versus 4% with usual care.
-
NMN raised NAD levels—but did it improve healthy aging?
A 24-week randomized trial found that high-dose NMN raised blood NAD? but did not improve measured physical performance, hearing, glucose, or HbA1c.
-
Gut microbes and heart failure: new clues, not a probiotic prescription
An observational study links gut microbes with heart-failure severity and improvement, without establishing a probiotic treatment.
-
Diet, gut microbes, and aging: what a new review can—and cannot—tell us
A new review connects diet and gut microbes with aging-related inflammation, while highlighting the gap between biological mechanisms and proven clinical benefits.
-
An RNA approach to preserving lean mass during weight loss—in mice
Animal research explores lean-mass preservation during GLP-1 weight loss. Human benefits and safety remain unproven.
-
Enicepatide trial: promising metabolic results, but heart benefits remain unproven
A sponsor-reported randomized trial found improvements in weight and blood sugar. Full comparisons and long-term cardiovascular outcomes remain uncertain.
Curiosity.
With perspective.
Health headlines move quickly. Research briefs should link to their sources, identify the kind of evidence, and explain what remains unknown.
Human trials, observational studies, and animal experiments answer different questions. Promising findings deserve attention—and careful interpretation.